Siemens Healthineers Reports Strong Q4 Earnings Growth

Siemens Healthineers showcased impressive results in its latest quarterly report, with net income and EPS growth reflecting strong operational performance. The company's revenue also increased, indicating positive trends ahead as they project continued growth for the upcoming fiscal year.

Date: 06-11-2024

AI Rating: 8

Siemens Healthineers has reported several key metrics indicating a strong financial performance. Here are the highlights from their report:

Net Income: The company achieved a net income growth of 15%, reaching 624 million euros compared to 540 million euros in the previous year.
Earnings Per Share (EPS): Basic earnings per share increased by 14% to 0.55 euro, up from 0.48 euro the previous year. Adjusted basic EPS also saw a rise to 0.67 euro from 0.60 euro.
Revenue Growth: Siemens Healthineers reported a revenue increase of 4.5%, totaling 6.33 billion euros, compared to 6.06 billion euros the year before. When excluding the COVID-19 antigen-test business, comparable revenue growth was 6.5%.
EBIT: Adjusted EBIT grew by 7% to 1.12 billion euros from 1.05 billion euros
Profit Margins: Adjusted EBIT margin improved slightly to 17.7%, compared to 17.2% last year.
Dividend: The company maintained a proposed dividend of 0.95 euro per share, unchanged from the previous year.

Looking forward, Siemens Healthineers expects adjusted basic earnings per share to range between 2.35 euros and 2.50 euros, along with a comparable revenue growth forecast of 5% to 6%.

In summary, the reported figures reflect strong operational performance and a positive outlook, which could boost investor confidence and potentially raise stock prices.

Stocks: SMMNY.PK